Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 15;16(2):259.
doi: 10.3390/nu16020259.

Bergamot Byproducts: A Sustainable Source to Counteract Inflammation

Affiliations
Review

Bergamot Byproducts: A Sustainable Source to Counteract Inflammation

Caterina Russo et al. Nutrients. .

Abstract

Chronic inflammation is the result of an acute inflammatory response that fails to eliminate the pathogenic agent or heal the tissue injury. The consequence of this failure lays the foundations to the onset of several chronic ailments, including skin disorders, respiratory and neurodegenerative diseases, metabolic syndrome, and, eventually, cancer. In this context, the long-term use of synthetic anti-inflammatory drugs to treat chronic illnesses cannot be tolerated by patients owing to the severe side effects. Based on this, the need for novel agents endowed with anti-inflammatory effects prompted to search potential candidates also within the plant kingdom, being recognized as a source of molecules currently employed in several therapeutical areas. Indeed, the ever-growing evidence on the anti-inflammatory properties of dietary polyphenols traced the route towards the study of flavonoid-rich sources, such as Citrus bergamia (bergamot) and its derivatives. Interestingly, the recent paradigm of the circular economy has promoted the valorization of Citrus fruit waste and, in regard to bergamot, it brought to light new evidence corroborating the anti-inflammatory potential of bergamot byproducts, thus increasing the scientific knowledge in this field. Therefore, this review aims to gather the latest literature supporting the beneficial role of both bergamot derivatives and waste products in different models of inflammatory-based diseases, thus highlighting the great potentiality of a waste re-evaluation perspective.

Keywords: Citrus bergamia; Citrus fruits; bergamot; byproducts; flavonoids; inflammation; natural products; polyphenols; waste valorization.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Path of bergamot processing from obtaining products with high economic interest to waste disposal. The waste valorization represents a great strategy both for recovery of compounds endowed with pharmacological properties and reduction of environmental disposal costs.
Figure 2
Figure 2
Main chemical composition of bergamot derivatives and byproducts. Bergamot juice is mostly characterized by flavonoids (i.e., naringin, neohesperidin, neoeriocitrin, melitidin and brutieridin), whereas bergamot seeds are characterized by limonoids (i.e., limonin and nomilin). Bergamot leaf oil is rich in monoterpenes (i.e., linalool, linalyl acetate and α-terpineol) and bergamot essential oil obtained from fruit peel is mainly composed of monoterpenes (i.e., limonene, linalool and linalyl acetate), coumarins (i.e., citropten) and psoralens (i.e., bergamottin and bergapten).
Figure 3
Figure 3
Radial map of the chemokines, enzymes and nuclear factors influenced by bergamot derivatives and byproducts.

Similar articles

Cited by

References

    1. Langgut D. The citrus route revealed: From Southeast Asia into the Mediterranean. HortScience. 2017;52:814–822. doi: 10.21273/HORTSCI11023-16. - DOI
    1. Wang R.X., Zhou M., Ma H.L., Qiao Y.B., Li Q.S. The Role of Chronic Inflammation in Various Diseases and Anti-inflammatory Therapies Containing Natural Products. ChemMedChem. 2021;16:1576–1592. doi: 10.1002/cmdc.202000996. - DOI - PubMed
    1. Cirmi S., Navarra M., Woodside J.V., Cantwell M.M. Citrus fruits intake and oral cancer risk: A systematic review and meta-analysis. Pharmacol. Res. 2018;133:187–194. doi: 10.1016/j.phrs.2018.05.008. - DOI - PubMed
    1. Mannucci C., Navarra M., Calapai F., Squeri R., Gangemi S., Calapai G. Clinical Pharmacology of Citrus bergamia: A Systematic Review. Phytother. Res. 2017;31:27–39. doi: 10.1002/ptr.5734. - DOI - PubMed
    1. Marino A., Paterniti I., Cordaro M., Morabito R., Campolo M., Navarra M., Esposito E., Cuzzocrea S. Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis. PharmaNutrition. 2015;3:53–59. doi: 10.1016/j.phanu.2015.03.002. - DOI

LinkOut - more resources